Literature DB >> 27681347

Dermoscopic diagnosis of amelanotic/hypomelanotic melanoma.

M A Pizzichetta1, H Kittler2, I Stanganelli3, G Ghigliotti4, M T Corradin5, P Rubegni6, S Cavicchini7, V De Giorgi8, R Bono9, M Alaibac10, S Astorino11, F Ayala12, P Quaglino13, G Pellacani14, G Argenziano15, D Guardoli14, F Specchio16, D Serraino17, R Talamini17.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 27681347     DOI： 10.1111/bjd.15093

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

1.  Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.

Authors:  Steven Vernali; Weston T Waxweiler; Patrick M Dillon; Peter A Kanetsky; Irene Orlow; Li Luo; Klaus J Busam; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  JAMA Dermatol       Date:  2017-10-01       Impact factor: 10.282

Review 2.  Dermoscopic Criteria, Histopathological Correlates and Genetic Findings of Thin Melanoma on Non-Volar Skin.

Authors:  Cesare Massone; Rainer Hofman-Wellenhof; Stefano Chiodi; Simona Sola
Journal:  Genes (Basel)       Date:  2021-08-23       Impact factor: 4.096

3.  Amelanotic Melanoma Concealed by Psoriasis.

Authors:  Philip Curman; Jan Lapins; Niki Radros; Britta Krynitz; Jakob D Wikström
Journal:  Acta Derm Venereol       Date:  2020-03-12       Impact factor: 3.875

4.  Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients.

Authors:  Giulia Ciccarese; Bruna Dalmasso; William Bruno; Paola Queirolo; Lorenza Pastorino; Virginia Andreotti; Francesco Spagnolo; Enrica Tanda; Giovanni Ponti; Cesare Massone; Francesco Drago; Aurora Parodi; Giovanni Ghigliotti; Maria Antonietta Pizzichetta; Paola Ghiorzo
Journal:  J Transl Med       Date:  2020-02-13       Impact factor: 5.531
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.